New molecular and epidemiological issues in mesothelioma: Role of SV40

Journal of Cellular Physiology

Volumn 180, Issue 2, 1999, Pages 167-172

  Carbone, Michele ^a   Fisher, Susan ^a   Powers, Amy ^a   Pass, Harvey I ^b   Rizzo, Paola ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; CANCER INHIBITION; CARCINOGENESIS; DNA DAMAGE; EPIDEMIOLOGICAL DATA; HAMSTER; INCIDENCE; MESOTHELIOMA; MOLECULAR DYNAMICS; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SIMIAN VIRUS 40; VIRUS EXPRESSION;

ANIMALS; CRICETINAE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MESOTHELIOMA; PAPILLOMAVIRUS INFECTIONS; PLEURAL NEOPLASMS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

ANIMALIA; CRICETINAE; DNA VIRUSES; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40; TUMOR VIRUS;

EID: 0033064918     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199908)180:2<167::AID-JCP4>3.0.CO;2-Q     Document Type: Review

References (34)

1. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL. 1992. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 51:73-80.
2. Butel J, Lednicky JA. 1999. Cell and molecular biology of SV40: implications for human infections and diseases. J Natl Cancer Inst 91:119-134.
3. Carbone M, Pompetti F, Cicala C, Nguyen P, Dixon K, Levine AS. 1991. Molecular basis of human cancer. New York: Plenum. p 195-206.
4. Carbone M, Pass HI, Rizzo P, Marinetti MR, DiMuzio M, Mew DJY, Levine AS, Procopio A. 1994. Simian virus 40 like sequences in human pleural mesothelioma. Oncogene 9:1781-1790.
5. Carbone M, Rizzo P, Procopio A, Pass HI, Gebhardt MC, Mangham C, Hansen M, Malkin DF, Bushart G, Pompetti F, Picci P, Levine AS, Bergsagel JD, Garcea RL. 1996. SV40-like sequences in human bone tumors. Oncogene 13:527-535.
6. Carbone M, Rizzo P, Pass HI. 1997a. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 15:1877-1888.
7. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridar V, de Bartolomeis A, Esposito V, Giuliano MT, Steinberg Sm, Levine AS, Giordano G, Pass HI. 1997b. Simian virus-40 large T antigen binds p53 in human mesotheliomas. Nature Med 3:908-912.
8. Cicala C, Pompetti F, Carbone M. 1993. SV40 induces mesotheliomas in hamsters. Am J Pathol 142:1524-1533.
9. Davis JMG, Addison J, Bolton RE, Donaldson K, Jones AD, Miller BG. 1985. Inhalation studies on the effects of tremolite and brucite dust in rats. Carcinogenesis 6:667-674.
10. De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, Carbone M, Giordano A. 1997. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus 40 large T antigen in mesotheliomas. Nature Med 3:913-916.
11. Eddy BE, Borman GS, Grubbs GE, Young RD. 1962. Identification of the oncogenic substance in rhesus monkey kidney cell cultures as simian virus 40. Virology 17:65-75.
12. Fisher SG, Weber L, Carbone M. 1999. Cancer risk associated with simian virus 40 contaminated poliovaccine. Anticancer Res (in press).
13. Hersterberg TW, Axten C, McConnell EE, Oberdoster G, Everitt J, Miller WC, Chevalier J, Chase GR, Thevenaz P. 1997. Chronic inhalation study of fiber glass and amosite asbestos in hamsters: twelve month preliminary results. Environ Health Perspect 105 (Suppl 5):1223-1229.
14. Hill AB, Hill ID. 1991. Bradford Hill's principles of medical statistics (12th ed). London: Edward Arnold. p 271-279.
15. Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammiletho L, Hovi T, Vainio H, Pass HI, Di Resta I, Carbone M, Linnainmaa K. 1999. SV40-like sequences were not detectable in Finnish mesotheliomas not exposed to SV40-contaminated poliovaccines. Mol Carcinogen (in press).
16. Huang H, Reis R, Yonekawa Y, Lopes MJ, Kleihues P, Ohgaki H. 1999. Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol 9: 33-44.
17. Jensen F, Koprowski H, Pagano JS, Ponten J, Ravdin RG. 1964. Autologous and homologous implantation of human cells transformed in vitro by SV40. J Natl Cancer Inst 32:917-932.
18. Kirchstein RL, Gerber P. 1962. Ependymomas produced after intracerebral inoculation of SV40 into newborn hamsters. Nature 195: 299-300.
19. Marsella JM, Liu BL, Vaslet CA, Kane AB. 1997. Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers. Environ Health Perspect 105 (Suppl 5):1069-1072.
20. Martini F, Iaccheri L, Carinici P, Corallini A, Gerosa M, Iuzzolino P, Barbanti-Brodano G, Tognon M. 1996. Simian virus 40 early region and large T antigen in human brain tumors, peripheral blood, and sperm fluids from healthy individuals. Cancer Res 56:4820-4825.
21. Martini F, Dolcetti R, Gloghini A, Iaccheri L, Carbone A, Boiocchi M, Tognon M. 1998. Simian virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 78(6)669-674.
22. Morris JA, Johnson KM, Aulisio GC, Chanock RM, Knight V. 1961. Clinical and serologic responses in volunteers given vacuolating virus (SV40) by respiratory route. Proc Soc Exp Biol Med 108:56-59.
23. Mortimer EA, Lepow ML, Gold E, Robins FC, Burton GJ, Fraumeni JF. 1981. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med 305:1517-1518.
24. Price B. 1997. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 145:211-218.
25. Pylev LN. 1980. Pretumorous lesions and pleural tumors induced by asbestos in rats, Syrian golden hamsters, and macaca mulatta (rhesus) monkeys. In: Wagner JC, editor. Biological effects of mineral fibers (Vol. 1). Lyon, France: International Agency for Research on Cancer. p 343-354.
26. Roggli VL, Sanfilippo F, Sheolburne J. Mesothelioma. 1992. In: Roggli VL, Greenberg SD, Pratt PC, editors. Pathology of asbestos and associated diseases. Boston: Little Brown. p 383-391.
27. Shein H, Enders JF. 1962. Transformation induced by simian virus 40 in human renal cell cultures. Proc Natl Acad Sci USA 48:1164-1169.
28. Smith WE, Hubert DD. 1974. The intrapleural route as a means for estimating carcinogenicity. In: Karbe E, Parke JF, editors. Experimental lung cancer carcinogenesis and biostatistics. New York: Springer-Verlag. p 92-101.
29. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF, Goedert JJ. 1998. Contamination of poliovirus vaccines with simian virus 40 (1995-1963) and subsequent cancer rates. JAMA 279:292-295.
30. Sweet BH, Hilleman MR. 1960. The vacuolating virus SV40. Proc Soc Exp Biol Med 105:420-427.
31. Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, Pooley FD, Rizzo P, Rusch V, Xiao GH. 1998. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res 58:4505-4509.
32. Wiman KG, Klein G. 1997. An old acquaintance resurfaces in human mesothelioma. Nature Med 3:839-840.
33. Xie YC, Hwang C, Overwijk W, Zeng Z, Eng MH, Mule JJ, Imperiale MJ, Restifo NP, Sanda MG. 1999. Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety modified simian virus 40 T antigen. J Natl Cancer Inst 91:169-175.
34. Yates DH, Corrin B, Stidolph PN, Brown K. 1997. Malignant mesothelioma in south-east England: clinicopathological experience of 272 cases. Thorax 52:507-512.